Table 1 |
|
|
Microarray data mining |
|
|
Analysis |
Finding |
|
|
|
|
RA-related genes in human chondrocytes differentially expressed in human chondrocytes that were stimulated with supernatant of RASFs versus NDSF stimulation |
- 110 pharmacological marker genes and relevant pathways of RA-related chondrocyte dysfunction |
|
KEGG pathway analysis |
|
|
|
|
|
Antirheumatic drug response signatures in human chondrocytes |
- Mechanism of drug action |
|
Differential expression of RA-related genes in human chondrocytes due to antirheumatic treatment of RASFs (stimulation of human chondroctyes with supernatant of drug-treated RASFs versus stimulation with supernatant of untreated RASFs) |
- 94 pharmacological marker genes and relevant pathways for stimulation of cartilage regeneration and suppression of inflammation |
|
Hierarchical clustering analysis, principal components analysis, and KEGG pathway analysis |
|
|
|
|
|
Validation of microarray data |
- Microarray data were confirmed for selected genes/proteins |
|
- Real-time reverse transcription-polymerase chain reaction |
|
|
- Enzyme-linked immunosorbent assay |
|
|
|
|
|
KEGG, Kyoto Encyclopaedia of Genes and Genomes; NDSF, healthy donor synovial fibroblast; RA, rheumatoid arthritis; RASF, rheumatoid arthritis synovial fibroblast. |
|
|
Andreas et al. Arthritis Research & Therapy 2009 11:R15 doi:10.1186/ar2605 |
|